What daily creatine dosing changes for midlife muscle maintenance

Researchers at Texas A&M University reported a 12-week randomized comparison on August 11, testing 10 grams per day of creatine monohydrate against placebo in 64 healthy adults aged 45 to 65, both with and without training plus modest dieting. Participants who did not exercise yet took creatine added around 2.4 pounds of lean tissue and recorded higher strength scores.

Volunteers first selected either a structured exercise and diet induced weight loss track or a non-exercise track. Random assignment to creatine or placebo then followed within each track. The training track combined resistance work and aerobic work three times weekly, and participants on that track ate to a planned small energy shortfall.

In the non-exercise track, creatine was associated with higher leg press strength and higher bench press strength across the 12 weeks. Gaining close to three pounds of lean tissue while fat mass fell were the participants assigned to creatine in the training and dieting track. The training and dieting track assigned to placebo showed minimal movement in lean tissue by comparison.

Creatine added to training was also linked to larger increases in leg and bench press strength and in time to exhaustion. No extra gain appeared for aerobic capacity. People taking creatine recorded a larger fall in body fat percentage than training and dieting without it, which the authors present as the first report of that pattern during creatine use with exercise and diet induced weight loss.

The midlife background here is preservation. Muscle and strength often decline with age and during weight loss, and holding onto lean tissue helps keep ordinary activity manageable. Support for lean tissue without a formal program may sound convenient, but structured training in this study was linked to the stronger strength response.

Several limits deserve attention. Since volunteers chose the exercise track before randomization, contrasts between exercisers and non-exercisers rest on weaker ground than contrasts of creatine against placebo. There is one 12 week study with 64 completers. It gives no long term follow up, no findings beyond ages 45 to 65, and no cognitive or health marker results mentioned in the paper title.

Dose and background behavior also require caution. The study examined 10 grams each day, not several intake levels. Food intake, protein intake and habitual movement in the non-exercise track could have influenced the outcomes. A 2025 analysis of 685 clinical trials from the same research group reported no significant difference in reported side effect frequency between creatine and placebo. The present trial was led by Dr. Richard Kreider, professor and director of the Exercise and Sport Nutrition Lab at Texas A&M, and supported by the WoodNext Foundation through the Texas A&M Foundation.

Treat this for now as a narrow finding rather than a standing routine. Creatine was linked to lean tissue and strength in this age group, showed a larger effect with training and dieting, and showed no added effect on aerobic capacity.